Amino Acid Substitution in HCV Core/NS5A Region and Genetic Variation Near IL28B Gene Affect Treatment Efficacy to Interferon plus Ribavirin Combination Therapy | Zendy

Norio Akuta | Zendy; Fumitaka Suzuki | Zendy; Miharu Hirakawa | Zendy; Yusuke Kawamura | Zendy; Hitomi Sezaki | Zendy; Yoshiyuki Suzuki | Zendy; Tetsuya Hosaka | Zendy; Masahiro Kobayashi | Zendy; Mariko Kobayashi | Zendy; Satoshi Saitoh | Zendy; Yasuji Arase | Zendy; Kenji Ikeda | Zendy; Kazuaki Chayama | Zendy; Yusuke Nakamura | Zendy; Hiromitsu Kumada | Zendy

Open Access

Amino Acid Substitution in HCV Core/NS5A Region and Genetic Variation Near <i>IL28B</i> Gene Affect Treatment Efficacy to Interferon plus Ribavirin Combination Therapy

Author(s) -

Norio Akuta,

Fumitaka Suzuki,

Miharu Hirakawa,

Yusuke Kawamura,

Hitomi Sezaki,

Yoshiyuki Suzuki,

Tetsuya Hosaka,

Masahiro Kobayashi,

Mariko Kobayashi,

Satoshi Saitoh,

Yasuji Arase,

Kenji Ikeda,

Kazuaki Chayama,

Yusuke Nakamura,

Hiromitsu Kumada

Publication year - 2011

Publication title -

intervirology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.641

H-Index - 61

eISSN - 1423-0100

pISSN - 0300-5526

DOI - 10.1159/000328327

Subject(s) - ribavirin , ns5a , amino acid substitution , virology , gene , genetic variation , interferon , affect (linguistics) , hepatitis c virus , pegylated interferon , substitution (logic) , biology , medicine , genetics , hepacivirus , virus , mutation , psychology , communication , computer science , programming language

To evaluate predictive factors of treatment efficacy to interferon (IFN)/ribavirin in patients infected with HCV genotype 1b (HCV-1b).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research